Dr. Stephen James Rulyak, MD

Dr. Rulyak practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Rulyak's NPI, 1447330436, was assigned on October 16, 2006. Dr. Rulyak graduated from Perelman School of Med at the University of Pennsylvania in 1997. Dr. Rulyak holds Washington license MD00038512.

Dr. Rulyak's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Dr. Rulyak's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Rulyak is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Rulyak to 2 more group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rulyak practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rulyak's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rulyak is licensed in Washington.

CMS data shows 300 Medicare services from Dr. Rulyak across 7 procedure codes in 2024, for 222 Medicare patients. Medicare paid $26,665 for them. Every service was in an office.

CMS counts 222 Medicare patients who saw Dr. Rulyak in 2024. The largest group is 65 to 74, with 121 patients. 63% of them have high cholesterol, and 61% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rulyak's median patient age at 61, with 55% women.

In 2024, Dr. Rulyak wrote 241 Medicare Part D claims for 173 patients. 71% of them were for generic drugs. CMS names the drug for 186 of them, across 8 drugs with 11 or more claims each, at $6,440 in total drug cost. In 2023, CMS named 102 claims across 4 drugs.

Dr. Rulyak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rulyak as offering telehealth. CMS counts 132 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rulyak, more than 82% of the clinicians it reports for that procedure.

CMS Open Payments shows 41 general payments to Dr. Rulyak from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $732.

Dr. Rulyak graduated from Perelman School of Med at the University of Pennsylvania in 1997.